Fluoride Delivery to Prevent White Spots During Orthodontic Treatment
Launched by LIVERPOOL UNIVERSITY HOSPITALS NHS FOUNDATION TRUST · Aug 6, 2021
Trial Information
Current as of April 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at different ways to apply fluoride to prevent white spots on teeth during orthodontic treatment with braces. These white spots are caused by a condition called enamel demineralization, which can happen when teeth are not properly protected while wearing braces. The study is specifically aimed at children and teenagers aged 11 to 16 who are about to start their orthodontic treatment with fixed metal braces.
To be eligible for this trial, participants must be generally healthy and not have any chronic diseases that require regular medical care. They should not have had significant dental work before, and they must be willing to take part in the study. If selected, participants will receive different fluoride treatments and will help researchers understand how effective each method is in protecting teeth during orthodontic treatment. This is a great opportunity for young patients to contribute to important dental research while taking care of their oral health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Planned to receive orthodontic treatment with upper and lower fixed orthodontic appliances (braces) either alone or following a period of functional appliance treatment.
- • 11-16 years of age inclusive at the start of the fixed orthodontic appliance treatment.
- • All genders.
- • Fit and well with no chronic disease necessitating regular hospital follow-up at hospital.
- • Willing to participate
- Exclusion Criteria:
- • Significant disabilities that may affect manual dexterity;
- • Any medical complication that would contraindicate the use of the fluoride treatments or milk products;
- • Previous orthodontic treatment except Phase I functional appliance treatment;
- • From areas that have fluoridated water supply\*;
- • Full coronal coverage restorations;
- • More than 2 missing anterior teeth;
- • Showing signs of systemic illness e.g. fever, cough, loss of taste/smell;
- • Any abnormality of face, lips e.g. cleft lip and/or palate or craniofacial abnormality or soft tissues of the mouth e.g. aphthous ulcers or connective tissue disorder.
About Liverpool University Hospitals Nhs Foundation Trust
Liverpool University Hospitals NHS Foundation Trust is a leading healthcare organization in the UK, dedicated to providing high-quality patient care, advancing medical research, and fostering education in the health sciences. With a strong commitment to innovation and excellence, the Trust actively participates in clinical trials aimed at improving treatment outcomes and enhancing healthcare delivery. By collaborating with academic institutions and industry partners, Liverpool University Hospitals NHS Foundation Trust strives to bridge the gap between research and clinical practice, ensuring that cutting-edge therapies and interventions are accessible to patients in the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liverpool, Merseyside, United Kingdom
Patients applied
Trial Officials
Heather Rogers
Study Chair
Liverpool University Hospitals NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials